Oura has agreed to acquire Counsel Health, an AI-native primary care company, the Finnish-founded wearables group said on 10 November 2026, in a deal reported at US$625m in cash.
Why Oura is buying Counsel Health
Counsel combines medical AI with board-certified physicians who can diagnose, treat, order labs and prescribe. Oura said the deal lets members move from biometric insight to on-demand care, with Counsel physicians able to see a member's Oura data only with permission.
Deal terms and financing
Oura's announcement did not state a price; several outlets reported US$625m in cash, subject to purchase price adjustments. Counsel founder Muthu Alagappan is expected to become Oura's chief clinical AI officer, and Counsel will continue serving its health plan and health system partners.
Regulatory approvals and timing
Completion is expected around the end of 2026, subject to customary conditions.
Market context
The deal follows Oura's earlier 2026 purchases of Doublepoint and Galen AI and comes weeks after it postponed a planned IPO.
